Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Mandatory HPV Vaccination Should Be Paired With Opt-Out Option, Says Study

XTALKS VITALS NEWS

There are currently two vaccines available – Merck’s Gardasil and GlaxoSmithKline’s Cervarix – which protect against the most common strains of the virus.

Tweetables from this article:

Tweet: Studies found that 21% of parents with children aged 11 to 17 were in favor of a law requiring HPV vaccination. http://buff.ly/2bIETC7"Studies found that 21% of parents with children aged 11 to 17 were in favor of a law requiring HPV vaccination."

Share this!

September 8, 2016 | by Sarah Massey, M.Sc.

Requiring children to get vaccinated against the sexually-transmitted human papillomavirus (HPV) has been a controversial issue among parents and politicians. As such, a new study suggests that most parents would only be in favour of mandatory vaccination if they were provided with an opt-out option.

HPV has been implicated in multiple cases of cervical cancer, along with a number of other types of the disease. There are currently two vaccines available – Merck’s Gardasil and GlaxoSmithKline’s Cervarix – which protect against the most common strains of the virus.

Merck’s Gardasil protects against HPV strains 6, 11, 16 and 18, While GlaxoSmithKline’s Cervarix only protects against types 16 and 18. These strains are responsible for approximately 70 percent of cervical cancer cases, and numerous other types of anal, vulvar, vaginal and penile cancer.

Gardasil brought in almost $2 billion in sales in 2015, making it one of Merck’s best-selling drugs. Despite its high sales numbers, the vaccine has faced considerable pushback from religious groups.

The vaccines are mainly targeted toward adolescent girls, who could be protected against HPV infection before they become sexually active. In 2014, about 40 percent of young girls in the US were given all three doses of the HPV vaccine, according to the Centers for Disease Control and Prevention (CDC).



The number of girls vaccinated that year was up from 38 percent in 2013. More young boys are also receiving the HPV vaccine, with 22 percent being vaccinated in 2014 compared to only 13 percent in 2013. Of course, more children would be vaccinated if the shot were required by law.

To assess the popularity of this idea, researchers at the University of North Carolina at Chapel Hill conducted a national study involving 1,501 parents. They found that 21 percent of parents with children aged 11 to 17 were in favour of a law requiring HPV vaccination. Interestingly, if an opt-out option was included, 57 percent of parents thought the law would be a good idea.

“School entry requirements are highly acceptable to parents, but only when implemented in a way that makes them ineffective,” said study author Noel T. Brewer, Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina. “Opt-outs lead to a large number of parents choosing not to vaccinate their children, and that makes requirements ineffective in raising vaccination rates.”


Keywords: Vaccination, Cancer


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor

March 23, 2017 - Most US patients hoping to get their PCSK9 inhibitor medications covered by their prescription drug plan are being denied, according to two new studied conducted by Amgen.

Featured In: Biotech News


Smartphone App Created Using Apple’s ResearchKit Used to Conduct Asthma Clinical Studies

March 22, 2017 - Researchers at the Icahn School of Medicine at Mount Sinai have conducted a large-scale, observational study of asthma patients using the Apple ResearchKit framework and the Asthma Health app on patients’ iPhones.

Featured In: Clinical Trials News


IBS Patients Taking Viberzi May Be at Increased Risk of Pancreatitis

March 22, 2017 - According to a recent drug safety communication issued by the US Food and Drug Administration (FDA), patients with irritable bowel syndrome (IBS) with diarrhea should not be treated using Viberzi (eluxadoline), if they do not have a gallbladder.

Featured In: Drug Safety News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

Will Pharmaceutical Serialization Solve All of Our Drug Counterfeiting Problems?

REGISTER FOR THESE WEBINARS

How to Improve the Speed and Efficiency of Your Clinical Trials


High Performance Computing for High Content Screening - A Case Study


The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review


Treatment of Psoriasis: Improvements Through Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.